Recent Event Highlights: FDA Approves Asenapine for Expanded Use in Schizophrenia, Bipolar Disorder - Medscape, FDA approves expanded use of Saphris - Drug Store News, Bipolar Disorder Medication Spotlight: Saphris, Fármaco para esquizofrenia da MSD aprovado para duas novas utilizações - RCM Pharma, Merck schizophrenia drug approved for 2 new uses - The Associated Press, Merck schizophrenia drug approved for two new uses, and 11 more...
Created by dipity on Aug 14, 2009
Last updated: 11/02/10 at 10:56 PM
Saphris has no followers yet. Be the first one to follow.
FDA Approves Asenapine for Expanded Use in Schizophrenia, Bipolar DisorderMedscapeSeptember 14, 2010 — Merck has announced that its antipsychotic asenapine (Saphris), in sublingual dissolving tablet form, has been approved for expanded ...
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEQvYwm-IqHRdV4WlSthY1cmvLjHw&url=http://www.medscape.com/viewarticle/728484
FDA, 머크 '사프리스 설하정' 적응증 추가 허가메디포뉴스이빛나 기자 FDA는 머크의 '사프리스(Saphris : asenapine) 설하정'에 대한 보충 신약허가(sNDA) 신청을 인정해 새로운 적응증 추가를 허가했다. ...
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE6NMN8we44hYiSjW6GYyaQvFVipA&url=http://www.medifonews.com/news/article.html?no%3D67252
Atypical Antipsychotic Medications: Saphris.
FDA approves expanded use of SaphrisDrug Store NewsSaphris now is indicated for the treatment of schizophrenia in adults, as monotherapy for the acute treatment of manic or mixed episodes associated with ...Merck Receives Approval From FDA For Expanded Indications ForPharmaceutical Online (press release)all 3 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFaGWz08tWHfXx9mU_NxhtW5ue8Aw&url=http://drugstorenews.com/story.aspx?id%3D151585%26menuid%3D787
Excerpt
...Bipolar Disorder Drug Sycrest.” Sycrest was first approved in the U.S. in 2009 where Merck markets it as Saphris. Sycrest/Saphris is a “sublingual asenapine drug for treating moderate to severe manic episodes in adult patients with bipolar I disorder” and...
Source Info
Psych Central
Related Topics
http://blogs.psychcentral.com/bipolar/2010/09/bipolar-disorder-medication-spotlight-saphris/
BMS nabs hep c partner Zymogenetics for $885M; Sun prevails in Taro's court ...FiercePharmaArticle > Merck's antipsychotic drug Saphris won the FDA nod for two additional uses: ongoing schizophrenia treatment and as an add-on to bipolar standbys ...and more »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG4udeUjUCK-FNq9mWFQupcp-EhtA&url=http://www.fiercepharma.com/story/bms-nabs-hep-c-partner-zymogenetics-885m-sun-prevails-taros-court-challenge/2010-09-08
RCM PharmaFármaco para esquizofrenia da MSD aprovado para duas novas utilizaçõesRCM PharmaA Merck Sharp & Dohme (MSD) anunciou terça-feira que o seu medicamento para a esquizofrenia Saphris® recebeu aprovação da FDA (entidade que regula os ...
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFXvgO-zK80casLxVdWn73lkvZL5g&url=http://www.rcmpharma.com/news/9604/51/Farmaco-para-esquizofrenia-da-MSD-aprovado-para-duas-novas-utilizacoes.html
Merck schizophrenia drug approved for 2 new usesThe Associated PressTRENTON, NJ — Merck & Co. said Tuesday its schizophrenia drug Saphris has been approved for two additional uses by the Food and Drug Administration. ...and more »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGoP6shAJ4FcnLgDMhi0NaQ7Hs9Sg&url=http://www.google.com/hostednews/ap/article/ALeqM5i-YEusCqEnGY0Xj3-rCi5N6rnV_gD9I39I8G0
Excerpt
...and neuroleptic malignant syndrome, a life-threatening neurological disorder. Merck has not yet reported sales figures for Saphris, also known as asenapine. Saphris, just launched in the fourth quarter, has lots of tough competition in the lucrative market...
Source Info
NorthJersey.com
Related Topics
http://www.northjersey.com/r?19=961&43=515652&44=102372634&32=4497&7=309037&40=http%3A%2F%2Fwww.northjersey.com%2Fnews%2Fbusiness%2F090710_Merck_schizophrenia_drug_approved_for_two_new_uses.html
Sycrest approved for use in EuropeChemist+DruggistThe treatment, which is manufactured by MSD and available as a sublingual tablet, is already available in the US under the brand name Saphris. ...Europe approves Merck & Co's asenapinePharma TimesMSD Receives European Approval of its Atypical Antipsychotic Medication ...PharmiWeb.com (press release)all 3 news articles »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEhgmgiblDHrx1O-yJbSiUnw0sx1Q&url=http://www.chemistanddruggist.co.uk/c/portal/layout?p_l_id%3D259751%26CMPI_SHARED_articleId%3D4291582%26CMPI_SHARED_ImageArticleId%3D4291582%26CMPI_SHARED_articleIdRelated%3D4291582%26CMPI_SHARED_ToolsArticleId%3D4291582%26CMPI_SHARED_CommentArticleId%3D4291582%26articleTitle%3DSycrest%2520approved%2520for%2520use%2520in%2520Europe
MSD Receives European Approval Of Its Atypical Antipsychotic Medication ...Medical News Today (press release)SYCREST is marketed as SAPHRIS® (asenapine) sublingual tablets in the United States. Efficacy of SYCREST was demonstrated in two similarly-designed, ...
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF-gCf3llHa-147-aSFvtyTwKIwLw&url=http://www.medicalnewstoday.com/articles/199997.php
Merck Blinks Over Plant Closings in The NetherlandsSeeking Alpha (blog)The Oss plant makes ingredients for the Saphris antipsychotic. For now, Merck has agreed to negotiate alternatives, including a possible sale. ...
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGAqlmgU9JnOXhwXr0K_-JN33IMGA&url=http://seekingalpha.com/article/223708-merck-blinks-over-plant-closings-in-the-netherlands
EU Sanctions Merck & Co.'s Sublingual Bipolar Disorder Drug SycrestGenetic Engineering NewsSycrest was first approved in the US in 2009, where it is marketed as Saphris® for the treatment of schizophrenia and mania in bipolar disorder. ...and more »
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEPpIxZbtJpghhE4NNmZC0SvIcGAA&url=http://www.genengnews.com/gen-news-highlights/eu-sanctions-msd-s-sublingual-bipolar-disorder-drug-sycrest/81243871/
Video Cam Direct Upload
A fight with invisible keyblades! Taken on Sunday of Connecticon 2010. Epic music is The Encounter from the KH soundtrack. Roxas: Saphris Sora: XXXRoxasNumber13XXX
Excerpt
...high, increased activity and restlessness, racing thoughts, talking fast, impulsive behavior, and a decreased need for sleep. Saphris is in a class of drugs called atypical antipsychotics. All atypical antipsychotics contain a boxed warning, the FDA’s strongest...
Source Info
Kansas City Infozine
http://www.infozine.com/news/stories/op/storiesView/sid/37120/
Excerpt
...high, increased activity and restlessness, racing thoughts, talking fast, impulsive behavior, and a decreased need for sleep. Saphris is in a class of drugs called atypical antipsychotics. All atypical antipsychotics contain a boxed warning, the FDA’s strongest...
Source Info
eMaxHealth
http://www.emaxhealth.com/2/94/32865/fda-approves-saphris-schizophrenia-bipolar-disorder-treatment.html
Excerpt
...or mixed episodes of bipolar I disorder in patients starting treatment and those who have discontinued previous treatment. SAPHRIS is an important addition to Schering-Plough's product portfolio, and represents the first US approval resulting from the Organon/Schering-Plough...
Source Info
Pharmaceutical Business Review
http://regulatoryaffairs.pharmaceutical-business-review.com/news/scheringplough_receives_fda_approval_for_saphris_090814
"one sheet" promotional poster, academia, academic, academics, access, account., acquire, acquisitions, act, acting, acting, actor, filmbay twitter rss feed award filmfest filmfestival film sundance festival video funny crazy award filmmaker filmmaking maker jesus filmbay.com
archives, areas, art, articles, artist, artists,, artwork, ask, attend, attract, auction, auctioning, auctions, audience, Audio, filmbay twitter rss feed award filmfest filmfestival film sundance festival video funny crazy award filmmaker filmmaking maker jesus filmbay.com
Excerpt
...investigational drug SAPHRIS (asenapine) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persistent negative symptoms of schizophrenia. Negative symptoms of schizophrenia include apathy, lack of emotion...
Source Info
Pharmaceutical Business Review
Related Topics
http://drugdiscovery.pharmaceutical-business-review.com/news/saphris_meets_primary_endpoint_in_extended_study_090724
"Hey Jude" by the beatles, -Across The Universe- movie version. speed doubled and then tripled for second video ... Chipmunk "Hey Jude" "Across the Universe" "The Beatles"
Excerpt
...treatment. The government oversight agency sent a letter to the pharmaceutical company asking for more data concerning Saphris, a stand-alone treatment for adults with schizophrenia and those with manic or mixed episodes associated with bipolar disorder. Schering-Plough ...
Source Info
Forbes
http://www.forbes.com/markets/2009/01/14/schering-plough-saphris-markets-equity-cx_lal_0114markets20.html?feed=rss_markets
Excerpt
...Corporation (NYSE: SGP) revealed top-line results of a long-term Phase III clinical study of its psychopharmacologic agent SAPHRIS(TM) (asenapine) demonstrating efficacy and safety in preventing relapse of schizophrenia. In this trial, asenapine was statistically...
Source Info
Medical News Today
http://www.medicalnewstoday.com/articles/130624.php
i was bored and i havent uploaded anything to youtube yet so blehh, i kno my room was dark and i kept looking at the computer screen, lol ... fast chipmunk mendez singing metro station moving along
This video was created using the Spore Creature Creator.
Update Sources